Sale!

EBP Gene Chondrodysplasia Punctata X-Linked Dominant Genetic Test

Original price was: $700.Current price is: $500.

-29%

The EBP Gene Chondrodysplasia Punctata X-Linked Dominant NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the EBP gene responsible for X-linked dominant chondrodysplasia punctata. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect genetic variations that cause characteristic bone abnormalities, skin conditions, and immune system disorders. The test is essential for individuals presenting with stippled epiphyses, ichthyosis, cataracts, or skeletal dysplasia. Priced at $500 USD, this advanced genetic analysis provides crucial information for accurate diagnosis, family planning decisions, and personalized medical management strategies. Results are typically available within 3-4 weeks from blood or DNA samples.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

EBP Gene Chondrodysplasia Punctata X-Linked Dominant NGS Genetic DNA Test

Comprehensive Genetic Testing for Bone and Skin Disorders

The EBP Gene Chondrodysplasia Punctata X-Linked Dominant NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for rare inherited disorders affecting bone development, skin health, and immune function. This advanced testing methodology provides crucial insights for patients and families affected by X-linked dominant chondrodysplasia punctata, enabling accurate diagnosis and informed medical decision-making.

What This Test Measures and Detects

Our comprehensive NGS-based genetic test specifically targets mutations in the EBP (emopamil binding protein) gene, which plays a critical role in cholesterol biosynthesis. The test identifies:

  • Pathogenic variants in the EBP gene associated with X-linked dominant chondrodysplasia punctata
  • Single nucleotide variants (SNVs) and small insertions/deletions (indels)
  • Genetic alterations affecting cholesterol metabolic pathways
  • Mutations responsible for Conradi-Hünermann-Happle syndrome

Clinical Indications: Who Should Consider This Test

This genetic test is recommended for individuals presenting with the following symptoms or clinical findings:

  • Newborns or infants with stippled epiphyses (punctate calcifications) on X-ray
  • Patients with asymmetric limb shortening or skeletal dysplasia
  • Individuals exhibiting ichthyosis (fish-scale skin) or other dermatological abnormalities
  • Patients with cataracts or other ocular abnormalities
  • Those with a family history of X-linked dominant inheritance patterns
  • Individuals with suspected Conradi-Hünermann syndrome
  • Patients with combined bone, skin, and immune system manifestations

Key Benefits of EBP Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages for patients and healthcare providers:

  • Accurate Diagnosis: Confirms or rules out X-linked dominant chondrodysplasia punctata with high precision
  • Family Planning Guidance: Enables informed reproductive decisions for affected families
  • Personalized Treatment: Guides targeted therapeutic interventions based on specific genetic findings
  • Prognostic Information: Helps predict disease progression and potential complications
  • Genetic Counseling: Provides basis for comprehensive family genetic counseling sessions
  • Early Intervention: Facilitates timely management of associated symptoms and conditions

Understanding Your Test Results

Our genetic specialists provide comprehensive interpretation of your EBP gene test results:

  • Positive Result: Indicates the presence of a pathogenic EBP gene mutation, confirming diagnosis of X-linked dominant chondrodysplasia punctata
  • Negative Result: Suggests absence of detectable EBP mutations, though clinical correlation remains essential
  • Variant of Uncertain Significance (VUS): Requires additional family studies and clinical correlation
  • Carrier Status: Important information for female relatives regarding transmission risk

All results include detailed explanations and recommendations for follow-up care with appropriate specialists.

Test Details and Pricing

Test Component Details
Test Name EBP Gene Chondrodysplasia Punctata X-Linked Dominant NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure optimal testing outcomes, we recommend:

  • Complete clinical history documentation for the patient undergoing testing
  • Genetic counseling session to create detailed family pedigree chart
  • Discussion of testing implications with qualified genetic counselor
  • Review of potential results and their clinical significance

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified collection centers ensures easy access to this essential genetic testing service.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about genetic conditions affect your health decisions. Our specialized EBP gene testing provides the answers you need for comprehensive medical management. Contact our genetic specialists today to schedule your test and begin your journey toward genetic understanding and personalized care.

Call or WhatsApp us now at +1(267) 388-9828 to book your EBP Gene Chondrodysplasia Punctata X-Linked Dominant NGS Genetic DNA Test and take control of your genetic health today!